Isolation of oxidative stress response mutants in Escherichia coli for their use as a genetic screen to identify new anti-mycobacterials as functional analogues of isoniazid

World Journal of Microbiology and Biotechnology

Volumn 22, Issue 8, 2006, Pages 791-798

  Sinha, P ^a   Santha Kumar, T R ^a   Darokar, M P ^a   Khanuja, S P S ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Escherichia coli; Isoniazid; katG; MBC; MIC; Mycobacterium tuberculosis; oxyR

Indexed keywords

BIOTECHNOLOGY; DISEASES; ESCHERICHIA COLI; ESSENTIAL OILS; GENES;

ISONIAZID; KATG; MBC; MIC; MYCOBACTERIUM TUBERCULOSIS (MTB); OXIDATIVE STRESS; OXYR;

MICROBIOLOGY;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM TUBERCULOSIS; SALMONELLA TYPHIMURIUM;

EID: 33747074850     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-005-9105-1     Document Type: Article

References (26)

1. Bauer, A.W., Kirby, W.M., Snerris, J.C. & Turck, M. 1966 Antibiotic sensitivity testing by standardized single disc method. American Journal of Clinical Pathology 45, 493-496.
2. Bloom, B.R. & Murray, C.J. 1992 Tuberculosis, commentary on a emergent killer. Science 257, 1055-1064.
3. Christman, M.F., Morgan, R.W., Jacobson, F.S. & Ames, B.N. 1985 Positive control of a regulon for defenses against oxidative stress and some heat shock proteins in Salmonella typhimurium. Cell 41, 753-762.
4. Christman, M.F., Storz, G. & Ames, B.N. 1989 OxyR, a positive regulator of hydrogen peroxide inducible genes in Escherichia coli and Salmonella typhimurium is homologous to a family of bacterial regulatory proteins. Proceedings of the National Academy of Sciences (USA) 86, 3484-3488.
5. Das, K.C., Chakraborty, D.P. & Bose, P.K. 1965 Antifungal activity of some constituents of Murraya koenigii Spreng. Experientia 21, 340.
6. Deretic, V., Phillip, W., Dhandayuthapani, S., Mudd, M.H., Curcic, R., Garbe, T., Heyms, B., Via, L.E. & Cole, S.T. 1995 Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative stress regulatory gene, implications for sensitivity to isoniazid. Molecular Microbiology 17, 889-900.
7. Deretic, V., Pagan-Ramos, E., Zhang, Y., Dhandayuthanpani, S. & Via, L.E. 1996 The extreme sensitivity of Mycobacterium tuberculosis to the front line antituberculosis drug isoniazid. Nature Biotechnology 14, 1557-1561.
8. Deretic, V., Song, J. & Pagar-Ramos, E. 1997 Loss of oxyR in Mycobacterium tuberculosis. Trends in Microbiology 5, 367-372.
9. Dye, C., Espinal, M.A., Watt, C.J., Mbiaga, C. & Williams, B.G. 2002 Worldwide incidence of Multidrug - Resistant Tuberculosis. The Journal of Infectious Diseases 185, 1197-1202.
10. Greenberg, J.T. & Demple, B. 1989 A global response induced in Escherichia coli by redox cycling agents overlaps with that induced by peroxide stress. Journal of Bacteriology 171, 3933-3939.
11. Heifets, L.B. & Iseman, M.D. 1985 Radiometric method for testing susceptibility of Mycobacteria to pyrazinamide in 7H12 broth. Journal of Clinical Microbiology 21, 200-204.
12. Heym, B., Alzari, P.M., Honore, N. & Cole, S.T. 1995 Missense mutations in the catalase-peroxidase gene, katG are associated with isoniazid resistance in Mycobacterium tuberculosis. Molecular Microbiology 15, 235-245.
13. Hong, E.J., Na, K.J., Choi, I.G., Choi, K.C. & Jeung, E.B. 2004 Antibacterial and antifungal effects of essential oils from coniferous trees. Biological and Pharmaceutical Bulletin 27, 863-866.
14. Kumar, S. 1976 Properties of adenyl cyclase and cyclic adenosine 3′-5′-monophosphate receptor protein deficient mutants of Escherichia coli. Journal of Bacteriology 125, 545-555.
15. Loewen, P.C. 1984 Isolation of catalase deficient Escherihia coli mutants and genetic mapping of katE, a locus that affects catalase activity. Journal of Bacteriology 57, 622-626.
16. Loewen, P.C., Triggs, B.L., George, C.S. & Hrabarchuk, B.E. 1985 Genetic mapping of katG, a locus that affects synthesis of the bifunctional catalase-peroxidase hydroperoxidase I in Escherichia coli. Journal of Bacteriology 162, 661-667.
17. Mitchison, D.A 1985 The action of antituberculosis drugs in short course chemotherapy. Tubercle 66, 219-225.
18. Mossa, J.S., El-Finaly, F.S. & Muhammad, I. 2004 Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in-vitro synergistic activity with isonicotinic acid hydrazide. Phytotherapy Research 18, 934-947.
19. Petersdorf, R.G. & Sherris, J.C. 1965 Methods and significance of in-vitro testing of bacterial sensitivity to drugs. American Journal of Medicine 39, 766-779.
20. Quemard, A., Sacchettini, J.C., Dessen, A., Vilcheze, C., Bittman, R., Jacobs, W.R. & Blanchard, J.S. 1995 Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34, 8235-8241.
21. Rosner, J.L. 1993 Susceptibilities of oxyR regulaon mutants of Escherichia coli and Salmonella typhimurium to isoniazid. Antimicrobial Agents and Chemotherapy 37, 2251-2253.
22. Sandra, M.N., Lau, C. & Wright, C.W. 2000 A review of antimycobacterial natural products. Phytotherapy Research 14, 303-322.
23. Srivastava, K.C. 1998 Extract of a spice-omum (Trachyspermum ammi) shows antiaggregatory effects and alters arachidonic acid metabolism in human platelets. Prostaglandins, Leukotrienes and Essential Fatty Acids 33, 1-6.
24. Storz, G. & Imlay, J.A. 1999 Oxidative stress. Current Opinions in Microbiology 2, 188-194.
25. Storz, G., Tartaglia, L.A. & Ames, B.N. 1990 Transcriptional regulator of oxidative stress-inducible genes, direct activation by oxidation. Science 248, 189-194.
26. Zhang, Y. & Young, D.B. 1993 Molecular mechanisms of isoniazid, a drug at the frontline of tuberculosis control. Trends in Microbiology 1, 109-113.